ציריך, May 09, 2025 (GLOBE NEWSWIRE) -- האקדמיה האירופית לאלרגיה ואימונולוגיה קלינית (EAACI), בשותפות עם המכון לאלרגיה של הונג קונג (HKIA), גאה להכריז על בית הספר לאלרגיה של EAACI בהונג קונג. ציון דרך משמעותי זה יתרחש בהונג קונג - עיר העולם של אסיה - מרכז …
ZURICH, May 09, 2025 (GLOBE NEWSWIRE) -- Akademi Alergi dan Imunologi Klinis Eropa (European Academy of Allergy and Clinical Immunology, EAACI), melalui kemitraan dengan Institut Alergi Hong Kong (Hong Kong Institute of Allergy, HKIA), dengan bangga …
チューリッヒ発, May 09, 2025 (GLOBE NEWSWIRE) -- 欧州アレルギー・臨床免疫学会 (European Academy of Allergy & Clinical Immunology) (EAACI) は香港アレルギー学会 (Hong Kong Institute of Allergy) (HKIA) と共同で、初のEAACI 香港アレルギースクールを開催する。 こ …
취리히, May 09, 2025 (GLOBE NEWSWIRE) -- 유럽 알레르기 임상 면역학회(EAACI)가 홍콩 알레르기 연구소(HKIA)와 협력하여 제1회 EAACI 홍콩 알레르기 스쿨 (EAACI Hong Kong Allergy School)을 개최하게 된다고 발표했다. 이 중요한 이정표는 동양과 서양이 만나고, 혁신과 전통이 어우러지며, 글로벌 마인드가 모이게 되는 역동적인 허브인 아시아의 세계 도시 홍콩에서 진행될 예정이다. “동양과 서양의 …
ZURICH, May 09, 2025 (GLOBE NEWSWIRE) -- European Academy of Allergy & Clinical Immunology (EAACI), dengan kerjasama Hong Kong Institute of Allergy (HKIA), dengan bangganya mengumumkan pelancaran pertama EAACI Hong Kong Allergy School. Pencapaian …
ZÜRICH, May 09, 2025 (GLOBE NEWSWIRE) -- Die European Academy of Allergy & Clinical Immunology (EAACI) gibt in Zusammenarbeit mit dem Hong Kong Institute of Allergy (HKIA) die Gründung der ersten EAACI Hong Kong Allergy School bekannt. Dieser …
ZURIQUE, May 09, 2025 (GLOBE NEWSWIRE) -- A Academia Europeia de Alergia e Imunologia Clínica (EAACI), em parceria com o Instituto de Alergia de Hong Kong (HKIA), tem a alegria de anunciar a primeira edição da EAACI Hong Kong Allergy School. Este …
ZURICH, 09 mai 2025 (GLOBE NEWSWIRE) -- L’Académie européenne d’allergologie et d’immunologie clinique (The European Academy of Allergy & Clinical Immunology, EAACI), en partenariat avec l’Institut d’allergologie de Hong Kong (Hong Kong Institute of …
苏黎世, May 09, 2025 (GLOBE NEWSWIRE) -- 欧洲过敏和临床免疫学学会（European Academy of Allergy & Clinical Immunology，简称 EAACI）联合香港过敏科医学会（Hong Kong Institute of Allergy，简称 HKIA）欣然宣布，首届 EAACI 香港过敏学校 (Hong Kong Allergy School) 即将开办。 这 …
蘇黎世, May 09, 2025 (GLOBE NEWSWIRE) -- 歐洲過敏及臨床免疫學會 (EAACI) 與香港過敏科醫學會 (HKIA) 攜手合作，隆重宣布首屆 EAACI 香港過敏學校開幕。 這項重要的里程碑活動將於香港這個充滿活力的亞洲國際都會展開，東方與西方在此交匯，創新與傳統碰撞，全球思潮匯聚一堂。 2025 年過敏學校以「東方遇見西方」為主題，朝着推動過敏及臨床免疫學跨洲合作邁出了大膽的一步。 …
ซูริก, May 09, 2025 (GLOBE NEWSWIRE) -- European Academy of Allergy & Clinical Immunology (EAACI) ซึ่งร่วมมือกับ Hong Kong Institute of Allergy (HKIA) ประกาศเปิดตัว EAACI Hong Kong Allergy School ด้วยความภาคภูมิใจ …
The performance digital marketing agency joins the growing movement of companies using business as a force for good. CIRENCESTER, GLOUCESTERSHIRE, UNITED KINGDOM, May 9, 2025 /EINPresswire.com/ -- Equimedia Ltd today announces its certification …
Greenbalance expands with 200+ new natural ingredients for DIY skincare, soap, and cosmetics – pure, chemical-free, and perfect for creators. HäSSLEHOLM, SKåNE, SWEDEN, May 9, 2025 /EINPresswire.com/ -- A lot is happening at Greenbalance right now. The …
ACCRA, GHANA, May 9, 2025 /EINPresswire.com/ -- Remittances, long viewed as personal safety nets for Ghanaian families, are now being recognized as powerful tools for economic transformation. A new call to action urges policymakers, financial …
Results support potential benefit of efruxifermin (EFX) to elicit fibrosis improvement in patients with compensated cirrhosis (F4 fibrosis) due to MASH 96-week data from SYMMETRY trial presented at EASL Congress 2025 SOUTH SAN FRANCISCO, Calif., May 09, …
GLENDALE, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- Court House Lawyers, a newly established firm in Glendale led by Managing Attorney George Mkrtchyan, Esq. has officially launched its legal services with an emphasis on Lemon Law and Personal …
First Quarter 2025 Commercial Channel revenue up 18% Integrity™ Implant System continues sequential growth and is on pace to more than double procedures in 2025 Key regulatory and clinical milestones achieved for Hyalofast®, Cingal®, and Integrity Updating …
~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no treatment-related serious adverse events ~ ~ Held Type B FDA meetings …
ALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS …
For Immediate Release: September 05, 2025 The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified …
04 days 16:48:55
